Original languageEnglish
Pages (from-to)332-342
Number of pages11
JournalLancet Child Adolesc. Health
Volume3
Issue number5
DOIs
Publication statusPublished - 2019

Keywords

  • melanocortin 1 receptor
  • adolescent
  • adult
  • aged
  • Article
  • Australia
  • Canada
  • cancer risk
  • cancer susceptibility
  • case control study
  • childhood disease
  • clinical assessment
  • cohort analysis
  • comparative study
  • controlled study
  • female
  • France
  • gene frequency
  • gene function
  • genetic analysis
  • genetic association
  • genetic variability
  • Greece
  • high risk patient
  • human
  • Italy
  • major clinical study
  • male
  • MC1R gene
  • melanoma
  • molecular pathology
  • Netherlands
  • prevalence
  • retrospective study
  • risk factor
  • Serbia
  • signal transduction
  • Spain
  • Sweden
  • Turkey (republic)
  • United States

Cite this

MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort : The Lancet Child and Adolescent Health. / IMI Study Group, the GEM Study Group, and the M-SKIP Study Group.

In: Lancet Child Adolesc. Health, Vol. 3, No. 5, 2019, p. 332-342.

Research output: Contribution to journalArticle

@article{b596457e12e54c9cade02240c497696c,
title = "MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort: The Lancet Child and Adolescent Health",
keywords = "melanocortin 1 receptor, adolescent, adult, aged, Article, Australia, Canada, cancer risk, cancer susceptibility, case control study, childhood disease, clinical assessment, cohort analysis, comparative study, controlled study, female, France, gene frequency, gene function, genetic analysis, genetic association, genetic variability, Greece, high risk patient, human, Italy, major clinical study, male, MC1R gene, melanoma, molecular pathology, Netherlands, prevalence, retrospective study, risk factor, Serbia, signal transduction, Spain, Sweden, Turkey (republic), United States",
author = "{IMI Study Group, the GEM Study Group, and the M-SKIP Study Group} and C. Pellegrini and F. Botta and D. Massi and C. Martorelli and F. Facchetti and S. Gandini and P. Maisonneuve and M.-F. Avril and F. Demenais and {Bressac-de Paillerets}, B. and V. Hoiom and A.E. Cust and H. Anton-Culver and S.B. Gruber and R.P. Gallagher and L. Marrett and R. Zanetti and T. Dwyer and N.E. Thomas and C.B. Begg and M. Berwick and S. Puig and M. Potrony and E. Nagore and P. Ghiorzo and C. Menin and A.M. Manganoni and M. Rodolfo and S. Brugnara and E. Passoni and L.K. Sekulovic and F. Baldini and G. Guida and A. Stratigos and F. Ozdemir and F. Ayala and R. Fernandez-de-Misa and P. Quaglino and G. Ribas and E. Migliano and I. Stanganelli and M.A. Pizzichetta and S. Raimondi and A. Ferrari and B. Valeri and G. Nazzaro and G. Tosti and G. Mazzarol and C. Carrera and S. Guida",
note = "Export Date: 14 November 2019 Correspondence Address: Raimondi, S.; Division of Epidemiology and Biostatistics, European Institute of Oncology IRCCSItaly; email: sara.raimondi@ieo.it",
year = "2019",
doi = "10.1016/S2352-4642(19)30005-7",
language = "English",
volume = "3",
pages = "332--342",
journal = "Lancet Child Adolesc. Health",
issn = "2352-4642",
publisher = "Elsevier B.V.",
number = "5",

}

TY - JOUR

T1 - MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort

T2 - The Lancet Child and Adolescent Health

AU - IMI Study Group, the GEM Study Group, and the M-SKIP Study Group

AU - Pellegrini, C.

AU - Botta, F.

AU - Massi, D.

AU - Martorelli, C.

AU - Facchetti, F.

AU - Gandini, S.

AU - Maisonneuve, P.

AU - Avril, M.-F.

AU - Demenais, F.

AU - Bressac-de Paillerets, B.

AU - Hoiom, V.

AU - Cust, A.E.

AU - Anton-Culver, H.

AU - Gruber, S.B.

AU - Gallagher, R.P.

AU - Marrett, L.

AU - Zanetti, R.

AU - Dwyer, T.

AU - Thomas, N.E.

AU - Begg, C.B.

AU - Berwick, M.

AU - Puig, S.

AU - Potrony, M.

AU - Nagore, E.

AU - Ghiorzo, P.

AU - Menin, C.

AU - Manganoni, A.M.

AU - Rodolfo, M.

AU - Brugnara, S.

AU - Passoni, E.

AU - Sekulovic, L.K.

AU - Baldini, F.

AU - Guida, G.

AU - Stratigos, A.

AU - Ozdemir, F.

AU - Ayala, F.

AU - Fernandez-de-Misa, R.

AU - Quaglino, P.

AU - Ribas, G.

AU - Migliano, E.

AU - Stanganelli, I.

AU - Pizzichetta, M.A.

AU - Raimondi, S.

AU - Ferrari, A.

AU - Valeri, B.

AU - Nazzaro, G.

AU - Tosti, G.

AU - Mazzarol, G.

AU - Carrera, C.

AU - Guida, S.

N1 - Export Date: 14 November 2019 Correspondence Address: Raimondi, S.; Division of Epidemiology and Biostatistics, European Institute of Oncology IRCCSItaly; email: sara.raimondi@ieo.it

PY - 2019

Y1 - 2019

KW - melanocortin 1 receptor

KW - adolescent

KW - adult

KW - aged

KW - Article

KW - Australia

KW - Canada

KW - cancer risk

KW - cancer susceptibility

KW - case control study

KW - childhood disease

KW - clinical assessment

KW - cohort analysis

KW - comparative study

KW - controlled study

KW - female

KW - France

KW - gene frequency

KW - gene function

KW - genetic analysis

KW - genetic association

KW - genetic variability

KW - Greece

KW - high risk patient

KW - human

KW - Italy

KW - major clinical study

KW - male

KW - MC1R gene

KW - melanoma

KW - molecular pathology

KW - Netherlands

KW - prevalence

KW - retrospective study

KW - risk factor

KW - Serbia

KW - signal transduction

KW - Spain

KW - Sweden

KW - Turkey (republic)

KW - United States

U2 - 10.1016/S2352-4642(19)30005-7

DO - 10.1016/S2352-4642(19)30005-7

M3 - Article

VL - 3

SP - 332

EP - 342

JO - Lancet Child Adolesc. Health

JF - Lancet Child Adolesc. Health

SN - 2352-4642

IS - 5

ER -